November 2026

Lung cancer can affect anyone with lungs.

That means anyone can get lung cancer. Screening is one of the most powerful tools we have to find it earlier, and more countries are rolling out national screening programmes. But screening is aimed at people at highest risk, so what about everyone else?

Every day, health systems carry out scans that capture part of the lung. These might be routine scans, or they might happen in emergency rooms.

Some of these scans will reveal small lesions called incidental pulmonary nodules (IPNs). Most are harmless, but some are an early sign of lung cancer. With the right processes in place to find, track and manage them, IPNs offer a route to earlier diagnosis for people who fall outside screening programmes, or live where screening isn’t available.

This Lung Cancer Awareness Month, we’re shining a spotlight on IPN management and looking at how health systems can make every incidental finding count.

In this issue:

  • Our new implementation toolkit for IPN management programmes, including a framework to assess your health system’s readiness
  • Network member Q&A: Dr Joelle Fathi on IPN management in practice
  • What’s still to come this month

To stay up to date with our work, please follow us on X, LinkedIn and YouTube. You can also visit our website or email us at networksecretariat@hpolicy.com.

  • The International Agency for Research on Cancer has published its evaluation of lung cancer screening, concluding that LDCT screening reduces lung cancer mortality when it’s appropriately targeted to people at high risk.
  • Poland has added lung cancer screening to its publicly funded health services, building on a five-year pilot.
  • Last month, Pope Leo XIV was diagnosed with early-stage lung cancer after a nodule was found in his lung during routine checks. Our IPN FAQs explain what lung nodules are and why follow-up matters.
  • In the US, the Lung Cancer Foundation of America has called for wider screening eligibility, noting that around half of people diagnosed would not have met the criteria for covered screening.
Our newly launched implementation toolkit for IPN management programmes helps health systems plan, design and deliver their own programmes.

Only around a third to a half of people with IPNs receive appropriate follow-up. Formal management programmes help change that, so lung cancer can be detected earlier in the whole population. Because such programmes build on imaging that is already happening, they can work in health systems with very different levels of resourcing, including those where screening is not yet feasible.

The toolkit is for anyone involved in planning or delivering health services, from policymakers and health system leaders to clinicians and administrators. Alongside the framework and user guide, it includes expert perspective videos, real-world case studies and supporting resources on guidelines, technical needs and health system data.

Explore the toolkit

No nodule overlooked: in conversation with Dr Joelle Fathi

What does IPN management look like day to day? We spoke to Network member Dr Joelle Fathi about what it means to her and what health systems can do to set up their own programmes.

A key theme is navigation. Without someone to guide people through follow-up, they can get lost between scans, appointments and specialists. Her advice for anyone starting out? If you already offer lung cancer screening, an IPN programme is a natural companion. If you don’t, build both at the same time.

Read the Q&A

Catch up on our autumn

  • Reflections from WCLC 2026. What the World Conference on Lung Cancer told us about turning policy ambition into action.
  • What stayed with us from the World Cancer Congress. Screening without diagnosis, diagnosis without timely treatment, treatment without follow-up: why every gap in the pathway costs lives.
  • Highlights from the Rescue Lung Society Conference. From a single GP phone call in Estonia to mobile CT in remote Australia, how countries are reaching the people who need screening most.
  • Germany makes lung cancer screening a reality. Our case study on how Germany launched a national screening programme in April 2026, and what its first six months show.

Still to come this Lung Cancer Awareness Month

Throughout November, we’ll be taking a closer look at more of the resources in the toolkit, including:

So keep an eye out for us on LinkedIn and be sure to check for updates via our news and analysis throughout the rest of the month.

Stay in touch

If someone has shared this newsletter with you, please subscribe to stay up to date with our latest news, blogs, projects and events.

If you would like to submit updates or news to be considered for inclusion in our newsletter, please get in touch.

Return